Whereas NPEPPS was recognized as a ubiquitous M1 class aminopeptidase participating in various cellular processes and controversially linked to the regulation of tauopathies (52–58), this enzyme now emerges as a pivotal, druggable interaction partner governing the response to cisplatin by regulating VRAC activity. Here, NPEPPS is linked to tauopathy.